Medical Care

Global In-Silico Drug Discovery Market Research Report 2025

The global market for In-Silico Drug Discovery was valued at US$ 2489 million in the year 2024 and is projected to reach a revised size of US$ 5410 million by 2031, growing at a CAGR of 11.9% during the forecast period.
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
This report aims to provide a comprehensive presentation of the global market for In-Silico Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Silico Drug Discovery.
The In-Silico Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Silico Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Silico Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software
Segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Silico Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Silico Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software as a Service (Cloud)
1.2.3 Consultancy as a Service
1.2.4 Software
1.3 Market by Application
1.3.1 Global In-Silico Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Industry
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Silico Drug Discovery Market Perspective (2020-2031)
2.2 Global In-Silico Drug Discovery Growth Trends by Region
2.2.1 Global In-Silico Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In-Silico Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 In-Silico Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 In-Silico Drug Discovery Market Dynamics
2.3.1 In-Silico Drug Discovery Industry Trends
2.3.2 In-Silico Drug Discovery Market Drivers
2.3.3 In-Silico Drug Discovery Market Challenges
2.3.4 In-Silico Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Silico Drug Discovery Players by Revenue
3.1.1 Global Top In-Silico Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global In-Silico Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global In-Silico Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In-Silico Drug Discovery Revenue
3.4 Global In-Silico Drug Discovery Market Concentration Ratio
3.4.1 Global In-Silico Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Silico Drug Discovery Revenue in 2024
3.5 Global Key Players of In-Silico Drug Discovery Head office and Area Served
3.6 Global Key Players of In-Silico Drug Discovery, Product and Application
3.7 Global Key Players of In-Silico Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Silico Drug Discovery Breakdown Data by Type
4.1 Global In-Silico Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global In-Silico Drug Discovery Forecasted Market Size by Type (2026-2031)
5 In-Silico Drug Discovery Breakdown Data by Application
5.1 Global In-Silico Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global In-Silico Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In-Silico Drug Discovery Market Size (2020-2031)
6.2 North America In-Silico Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In-Silico Drug Discovery Market Size by Country (2020-2025)
6.4 North America In-Silico Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Silico Drug Discovery Market Size (2020-2031)
7.2 Europe In-Silico Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In-Silico Drug Discovery Market Size by Country (2020-2025)
7.4 Europe In-Silico Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Silico Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific In-Silico Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In-Silico Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific In-Silico Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Silico Drug Discovery Market Size (2020-2031)
9.2 Latin America In-Silico Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In-Silico Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America In-Silico Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Silico Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa In-Silico Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In-Silico Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa In-Silico Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River In-Silico Drug Discovery Introduction
11.1.4 Charles River Revenue in In-Silico Drug Discovery Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Certara USA, Inc.
11.2.1 Certara USA, Inc. Company Details
11.2.2 Certara USA, Inc. Business Overview
11.2.3 Certara USA, Inc. In-Silico Drug Discovery Introduction
11.2.4 Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025)
11.2.5 Certara USA, Inc. Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec In-Silico Drug Discovery Introduction
11.3.4 Evotec Revenue in In-Silico Drug Discovery Business (2020-2025)
11.3.5 Evotec Recent Development
11.4 Dassault System (Biovia)
11.4.1 Dassault System (Biovia) Company Details
11.4.2 Dassault System (Biovia) Business Overview
11.4.3 Dassault System (Biovia) In-Silico Drug Discovery Introduction
11.4.4 Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2020-2025)
11.4.5 Dassault System (Biovia) Recent Development
11.5 Albany Molecular Research Inc. (AMRI)
11.5.1 Albany Molecular Research Inc. (AMRI) Company Details
11.5.2 Albany Molecular Research Inc. (AMRI) Business Overview
11.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Introduction
11.5.4 Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2020-2025)
11.5.5 Albany Molecular Research Inc. (AMRI) Recent Development
11.6 Selvita
11.6.1 Selvita Company Details
11.6.2 Selvita Business Overview
11.6.3 Selvita In-Silico Drug Discovery Introduction
11.6.4 Selvita Revenue in In-Silico Drug Discovery Business (2020-2025)
11.6.5 Selvita Recent Development
11.7 Schrödinger, Inc.
11.7.1 Schrödinger, Inc. Company Details
11.7.2 Schrödinger, Inc. Business Overview
11.7.3 Schrödinger, Inc. In-Silico Drug Discovery Introduction
11.7.4 Schrödinger, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025)
11.7.5 Schrödinger, Inc. Recent Development
11.8 GVK BIO
11.8.1 GVK BIO Company Details
11.8.2 GVK BIO Business Overview
11.8.3 GVK BIO In-Silico Drug Discovery Introduction
11.8.4 GVK BIO Revenue in In-Silico Drug Discovery Business (2020-2025)
11.8.5 GVK BIO Recent Development
11.9 OpenEye Scientific Software
11.9.1 OpenEye Scientific Software Company Details
11.9.2 OpenEye Scientific Software Business Overview
11.9.3 OpenEye Scientific Software In-Silico Drug Discovery Introduction
11.9.4 OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2020-2025)
11.9.5 OpenEye Scientific Software Recent Development
11.10 Chemical Computing Group (CCG)
11.10.1 Chemical Computing Group (CCG) Company Details
11.10.2 Chemical Computing Group (CCG) Business Overview
11.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Introduction
11.10.4 Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2020-2025)
11.10.5 Chemical Computing Group (CCG) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In-Silico Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software as a Service (Cloud)
Table 3. Key Players of Consultancy as a Service
Table 4. Key Players of Software
Table 5. Global In-Silico Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In-Silico Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global In-Silico Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global In-Silico Drug Discovery Market Share by Region (2020-2025)
Table 9. Global In-Silico Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global In-Silico Drug Discovery Market Share by Region (2026-2031)
Table 11. In-Silico Drug Discovery Market Trends
Table 12. In-Silico Drug Discovery Market Drivers
Table 13. In-Silico Drug Discovery Market Challenges
Table 14. In-Silico Drug Discovery Market Restraints
Table 15. Global In-Silico Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global In-Silico Drug Discovery Market Share by Players (2020-2025)
Table 17. Global Top In-Silico Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Silico Drug Discovery as of 2024)
Table 18. Ranking of Global Top In-Silico Drug Discovery Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by In-Silico Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of In-Silico Drug Discovery, Headquarters and Area Served
Table 21. Global Key Players of In-Silico Drug Discovery, Product and Application
Table 22. Global Key Players of In-Silico Drug Discovery, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In-Silico Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global In-Silico Drug Discovery Revenue Market Share by Type (2020-2025)
Table 26. Global In-Silico Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global In-Silico Drug Discovery Revenue Market Share by Type (2026-2031)
Table 28. Global In-Silico Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global In-Silico Drug Discovery Revenue Market Share by Application (2020-2025)
Table 30. Global In-Silico Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global In-Silico Drug Discovery Revenue Market Share by Application (2026-2031)
Table 32. North America In-Silico Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America In-Silico Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America In-Silico Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe In-Silico Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe In-Silico Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe In-Silico Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific In-Silico Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific In-Silico Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific In-Silico Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America In-Silico Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America In-Silico Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America In-Silico Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa In-Silico Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa In-Silico Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa In-Silico Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
Table 47. Charles River Company Details
Table 48. Charles River Business Overview
Table 49. Charles River In-Silico Drug Discovery Product
Table 50. Charles River Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 51. Charles River Recent Development
Table 52. Certara USA, Inc. Company Details
Table 53. Certara USA, Inc. Business Overview
Table 54. Certara USA, Inc. In-Silico Drug Discovery Product
Table 55. Certara USA, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 56. Certara USA, Inc. Recent Development
Table 57. Evotec Company Details
Table 58. Evotec Business Overview
Table 59. Evotec In-Silico Drug Discovery Product
Table 60. Evotec Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 61. Evotec Recent Development
Table 62. Dassault System (Biovia) Company Details
Table 63. Dassault System (Biovia) Business Overview
Table 64. Dassault System (Biovia) In-Silico Drug Discovery Product
Table 65. Dassault System (Biovia) Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 66. Dassault System (Biovia) Recent Development
Table 67. Albany Molecular Research Inc. (AMRI) Company Details
Table 68. Albany Molecular Research Inc. (AMRI) Business Overview
Table 69. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product
Table 70. Albany Molecular Research Inc. (AMRI) Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 71. Albany Molecular Research Inc. (AMRI) Recent Development
Table 72. Selvita Company Details
Table 73. Selvita Business Overview
Table 74. Selvita In-Silico Drug Discovery Product
Table 75. Selvita Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 76. Selvita Recent Development
Table 77. Schrödinger, Inc. Company Details
Table 78. Schrödinger, Inc. Business Overview
Table 79. Schrödinger, Inc. In-Silico Drug Discovery Product
Table 80. Schrödinger, Inc. Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 81. Schrödinger, Inc. Recent Development
Table 82. GVK BIO Company Details
Table 83. GVK BIO Business Overview
Table 84. GVK BIO In-Silico Drug Discovery Product
Table 85. GVK BIO Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 86. GVK BIO Recent Development
Table 87. OpenEye Scientific Software Company Details
Table 88. OpenEye Scientific Software Business Overview
Table 89. OpenEye Scientific Software In-Silico Drug Discovery Product
Table 90. OpenEye Scientific Software Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 91. OpenEye Scientific Software Recent Development
Table 92. Chemical Computing Group (CCG) Company Details
Table 93. Chemical Computing Group (CCG) Business Overview
Table 94. Chemical Computing Group (CCG) In-Silico Drug Discovery Product
Table 95. Chemical Computing Group (CCG) Revenue in In-Silico Drug Discovery Business (2020-2025) & (US$ Million)
Table 96. Chemical Computing Group (CCG) Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report


List of Figures
Figure 1. In-Silico Drug Discovery Picture
Figure 2. Global In-Silico Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In-Silico Drug Discovery Market Share by Type: 2024 VS 2031
Figure 4. Software as a Service (Cloud) Features
Figure 5. Consultancy as a Service Features
Figure 6. Software Features
Figure 7. Global In-Silico Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global In-Silico Drug Discovery Market Share by Application: 2024 VS 2031
Figure 9. Contract Research Organization Case Studies
Figure 10. Pharmaceutical Industry Case Studies
Figure 11. Academic and Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. In-Silico Drug Discovery Report Years Considered
Figure 14. Global In-Silico Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global In-Silico Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global In-Silico Drug Discovery Market Share by Region: 2024 VS 2031
Figure 17. Global In-Silico Drug Discovery Market Share by Players in 2024
Figure 18. Global Top In-Silico Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Silico Drug Discovery as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by In-Silico Drug Discovery Revenue in 2024
Figure 20. North America In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America In-Silico Drug Discovery Market Share by Country (2020-2031)
Figure 22. United States In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe In-Silico Drug Discovery Market Share by Country (2020-2031)
Figure 26. Germany In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific In-Silico Drug Discovery Market Share by Region (2020-2031)
Figure 34. China In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America In-Silico Drug Discovery Market Share by Country (2020-2031)
Figure 42. Mexico In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa In-Silico Drug Discovery Market Share by Country (2020-2031)
Figure 46. Turkey In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE In-Silico Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Charles River Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 50. Certara USA, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 51. Evotec Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 52. Dassault System (Biovia) Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 53. Albany Molecular Research Inc. (AMRI) Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 54. Selvita Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 55. Schrödinger, Inc. Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 56. GVK BIO Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 57. OpenEye Scientific Software Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 58. Chemical Computing Group (CCG) Revenue Growth Rate in In-Silico Drug Discovery Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies